HPV Information Center

Inaccurate Parental Reporting of HPV Vaccination Linked to Multilevel Sociodemographic Factors

Inaccurate Parental Reporting of HPV Vaccination Linked to Multilevel Sociodemographic Factors

Parents of racial or ethnic minority adolescents were more likely to inaccurately report HPV vaccination initiation.

Healthday Many Teens Not Up to Date on HPV Vaccination

Many Teens Not Up to Date on HPV Vaccination

Only 15.7 and 34.8% of teens completed HPV vaccination before turning 13 and 15.

News Prevalence of Anogenital Warts Declining Across Populations

Prevalence of Anogenital Warts Declining Across Populations

The prevalence of anogenital warts has decreased, with significant declines observed in specific populations.

News Self-Sampling Strategy to Encourage Screening for High-Risk Human Papillomavirus

Self-Sampling Strategy to Encourage Screening for High-Risk Human Papillomavirus

Women who used a self-screening assay for high-risk human papillomavirus had similar test results to those who were screened by a clinician.

Healthday Hispanics With HIV Face Higher Risk for HPV-Related Cancer

Hispanics With HIV Face Higher Risk for HPV-Related Cancer

HIV-infected Hispanics have an increased risk for human papillomavirus-related cancers than Hispanics in the general population.

Healthday Positive HPV Status Tied to Better Cervical Cancer Prognosis

Positive HPV Status Tied to Better Cervical Cancer Prognosis

Women with high-risk human papillomavirus-positive cervical tumors have a substantially better prognosis than women with hrHPV-negative tumors.

News Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

Gardasil 9 Approved for Use in Women and Men 27 Through 45 Years Old

The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 years of age with a median duration of follow-up of 3.5 years post-dose 3.

Healthday More Than 14 Million Preteens Need to Receive HPV Vaccine

More Than 14 Million Preteens Need to Receive HPV Vaccine

14 million need to receive two doses of vaccine to reach goal of 80% vaccination by 2026.

News HPV Vaccination Decreases High-Grade Cervical Lesions in Women

HPV Vaccination Decreases High-Grade Cervical Lesions in Women

From 2008 to 2015, both cervical intraepithelial neoplasia grades 2, 3 and adenocarcinoma in situ rates and cervical cancer screening declined in women age 18 to 24 years.

Healthday USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every 3 years from age 21; different screening options from age 30 to 65.

Sign Up for Free e-newsletters